165
The company is working on vaccines against the syncytial virus and against melanoma: for both it has obtained breakthrough therapy, the accelerated approval procedure, from the American FDA. What has been done with the anti-Covid vaccines, Moderna explained, has allowed research to proceed quickly, so much so that the equivalent of 15 years of progress has been achieved in just 12 to 18 months